Chemical and Allied Products Plc (NGX: CAP)
Nigeria
· Delayed Price · Currency is NGN
38.00
0.00 (0.00%)
At close: Dec 24, 2024
NGX: CAP Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 32,277 | 23,890 | 19,208 | 14,208 | 8,876 | 8,411 | Upgrade
|
Revenue Growth (YoY) | 50.75% | 24.37% | 35.20% | 60.07% | 5.54% | 9.65% | Upgrade
|
Cost of Revenue | 20,317 | 15,131 | 11,684 | 9,650 | 5,134 | 4,438 | Upgrade
|
Gross Profit | 11,960 | 8,759 | 7,524 | 4,558 | 3,742 | 3,973 | Upgrade
|
Selling, General & Admin | 8,196 | 6,072 | 4,706 | 3,342 | 2,245 | 1,952 | Upgrade
|
Other Operating Expenses | -600.8 | -486.74 | -244.74 | -134.92 | -87.8 | -101.51 | Upgrade
|
Operating Expenses | 7,563 | 5,553 | 4,430 | 3,244 | 2,186 | 1,851 | Upgrade
|
Operating Income | 4,397 | 3,206 | 3,095 | 1,314 | 1,556 | 2,122 | Upgrade
|
Interest Expense | -54.61 | -155.35 | -33.55 | -7.61 | -1.31 | -0.87 | Upgrade
|
Interest & Investment Income | 171.99 | 311.7 | 174.31 | 180.48 | 249.79 | 424.25 | Upgrade
|
Currency Exchange Gain (Loss) | 865.68 | 369.55 | 207.46 | 76.11 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -27.2 | 0 | - | - | - | - | Upgrade
|
EBT Excluding Unusual Items | 5,353 | 3,732 | 3,443 | 1,563 | 1,805 | 2,546 | Upgrade
|
Gain (Loss) on Sale of Assets | 36.33 | 46.58 | 6.47 | 164.27 | 1.18 | 0.19 | Upgrade
|
Asset Writedown | - | - | -5.02 | - | - | - | Upgrade
|
Pretax Income | 5,389 | 3,779 | 3,444 | 1,727 | 1,806 | 2,546 | Upgrade
|
Income Tax Expense | 1,796 | 1,264 | 1,068 | 604.92 | 582.61 | 803.65 | Upgrade
|
Net Income | 3,594 | 2,515 | 2,376 | 1,123 | 1,223 | 1,742 | Upgrade
|
Net Income to Common | 3,594 | 2,515 | 2,376 | 1,123 | 1,223 | 1,742 | Upgrade
|
Net Income Growth | 37.84% | 5.83% | 111.67% | -8.22% | -29.79% | -14.16% | Upgrade
|
Shares Outstanding (Basic) | 815 | 815 | 815 | 788 | 700 | 700 | Upgrade
|
Shares Outstanding (Diluted) | 825 | 825 | 815 | 788 | 700 | 700 | Upgrade
|
Shares Change (YoY) | 1.20% | 1.20% | 3.36% | 12.61% | - | - | Upgrade
|
EPS (Basic) | 4.41 | 3.09 | 2.92 | 1.42 | 1.75 | 2.49 | Upgrade
|
EPS (Diluted) | 4.36 | 3.05 | 2.92 | 1.42 | 1.75 | 2.49 | Upgrade
|
EPS Growth | 36.53% | 4.58% | 104.79% | -18.50% | -29.79% | -14.16% | Upgrade
|
Free Cash Flow | -1,309 | 2,868 | 635.85 | -1,893 | 876.69 | 1,482 | Upgrade
|
Free Cash Flow Per Share | -1.59 | 3.48 | 0.78 | -2.40 | 1.25 | 2.12 | Upgrade
|
Dividend Per Share | 1.550 | 1.550 | 1.550 | 1.250 | 2.100 | - | Upgrade
|
Dividend Growth | 0% | 0% | 24.00% | -40.48% | - | - | Upgrade
|
Gross Margin | 37.05% | 36.67% | 39.17% | 32.08% | 42.16% | 47.24% | Upgrade
|
Operating Margin | 13.62% | 13.42% | 16.11% | 9.25% | 17.53% | 25.23% | Upgrade
|
Profit Margin | 11.13% | 10.53% | 12.37% | 7.90% | 13.78% | 20.71% | Upgrade
|
Free Cash Flow Margin | -4.05% | 12.01% | 3.31% | -13.33% | 9.88% | 17.62% | Upgrade
|
EBITDA | 4,881 | 3,625 | 3,448 | 1,539 | 1,702 | 2,253 | Upgrade
|
EBITDA Margin | 15.12% | 15.17% | 17.95% | 10.83% | 19.17% | 26.79% | Upgrade
|
D&A For EBITDA | 483.63 | 418.58 | 353.88 | 225.1 | 145.59 | 130.96 | Upgrade
|
EBIT | 4,397 | 3,206 | 3,095 | 1,314 | 1,556 | 2,122 | Upgrade
|
EBIT Margin | 13.62% | 13.42% | 16.11% | 9.25% | 17.53% | 25.23% | Upgrade
|
Effective Tax Rate | 33.32% | 33.45% | 31.01% | 35.02% | 32.26% | 31.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.